This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained 2.85 points to 679.93 Thursday. Joe Boury's halted, four-year-old capital pool shell, Plicit Capital Corp. (PLP), has hired an adviser and increased its private placement. Currently, the shell is working on its qualifying transaction, which is the acquisition of 3D Signatures Inc., a medical device developer in Manitoba. Plicit will roll back 1 for 2, leaving it with 5.05 million postconsolidated shares issued, then issue 23,138,678 postconsolidated shares to 3D Signatures' shareholders.

In connection with its QT, Plicit is selling a private placement of postconsolidated shares at 35 cents through Haywood Securities Inc. The shell has increased this financing to $5-million from $3-million, following a $1-million subscription commitment from pharmaceutical products distributor Knight Therapeutics Inc. (GUD: $8.20). Plicit has also signed an agreement with Knight, under which Knight will provide business advisory services to Plicit for three years at $250,000 a year. The services will include advisory services from Knight's president, Jonathan Goodman. Mr. Goodman was a co-founder and the president of Paladin Labs Inc., which was acquired by drug maker Endo International PLC (ENL: $19.68) in February, 2014. Mr. Goodman's Knight Therapeutics was spun out of Paladin Labs in that same transaction.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS